keccers
@keccers.eth
Bryan Johnson has been proactively trying to get ahead of this NYT piece — it’s here It says that Bryan is extremely controlling of his employees and wields this control through extraordinary confidentiality agreements I don’t expect a ton of sympathy for the worker here. I understand how you could have a positive perspective on these agreements. It is an individual’s choice whether or not to work for Bryan. BUT — the piece also suggests there may be more than meets the eye to the protocol, which many follow. Bryan’s medical advisor featured in the Netflix documentary, resigned over concerns related to the protocol. In Bryan’s own study of 1700 people, many people had adverse effects when following Blueprint. When Bryan reported on the work, he released data on only 300 participants Blueprint clearly works for many if not all and I’m not trying to tell you to stop eating nutty pudding. But be judicious in the advice you take. Don’t be a blind follower Unlocked gift link in reply 👇
4 replies
3 recasts
25 reactions
keccers
@keccers.eth
https://www.nytimes.com/2025/03/21/technology/bryan-johnson-blueprint-confidentiality-agreements.html?unlocked_article_code=1.504.Sk0h.NbYkA0Eo6LC6&smid=nytcore-ios-share&referringSource=articleShare
0 reply
1 recast
5 reactions
Metaphorical
@hyp
30% of clinical trials fail due to toxicity. Most treatments are more likely to harm than help (until thoroughly tested.)
1 reply
0 recast
3 reactions
Omishon 💜ᖽ 🎩
@omishon
Due diligence such an overlooked aspect of trying new things
1 reply
0 recast
1 reaction
Matt
@mattlee
I don’t want to be a hater but is it just me or is this really badly written? It seems like college freshman level to me. Also describing the pursuit of everlasting youth as an “oddball fascination” is one of the craziest things I’ve ever read haha
1 reply
0 recast
0 reaction
